BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Monday, March 18, 2024
Home
»
Newsletters
» BioWorld Asia
BioWorld Asia
Sep. 23, 2009
View Archived Issues
Pieris Getting $10M Up Front in Allergan Ophthalmology Deal
Pieris AG is getting an up-front payment of $10 million from Allergan Inc., as part of a licensing deal under which the latter firm will gain access to its anticalin technology in ophthalmology indications. (BioWorld International)
Read More
Wellcome Trust, Merck Team Up to Create £90M Vaccine Program
Read More
New Tools to Allow Deeper Scrutiny of Cancer-Fighting Cells
Read More
After Rebuffing Potential Suitor, Renovo Slashes Staffing, R&D
Read More
Cell Medica Raises £1.95M to Expand Cell Therapy Work
Read More
Signaling Systems the Focus on $22M Push in Systems Biology
Read More
AGI Therapeutics' New Strategy: Extending into Niche Markets
Read More
Other News To Note
Read More